USE OF FULVESTRANT IN THE TREATMENT OF RESISTANT BREAST CANCER
摘要
<p>The invention relates to the use of fulvestrant in the treatment of breast cancer in patients who have previously been treated with an Selective Estrogen Receptor Modulator (SERM) and an aromatase inhibitor.</p>
